Latest News View All

 Integrated Direct-to-Biology (D2B) Platform

Looking for a solution to accelerate your drug discovery processes? Introducing WuXi AppTec’s Integrated Direct-to-Biology (D2B) platform—a cost-effective and time-saving approach that empowers small molecule...

Continue Reading

WuXi Biology HTS Platform 2.0 Launch

We are excited to announce the official launch of WuXi Biology HTS Platform 2.0, an advanced platform designed to enhance hit discovery and accelerate drug...

Continue Reading

OncoWuXi’s New Antibody Library Launch: An Innovative Step Forward in Drug Development

[Detection Antibodies + Target Development + High-Standard Controls] Empowering the Entire Drug Development Verification Process: In 2024 the OncoWuXi database successfully upgraded to a pharmacology...

Continue Reading

Upcoming EventsView All

Event Image
August 11, 2025 - August 13, 2025
Philadelphia, PA

Immuno-Oncology Summit

Learn More
Event Image
August 14, 2025 - August 15, 2025
Boston, MA

13th International Symposium on DNA-Encoded Chemical Libraries

Learn More
Event Image
September 9, 2025 - September 18, 2025
Copenhagen, Basel, San Diego, and Boston

WuXi Science Forums

Learn More

Upcoming WebinarsView All

Strategies for Advancing Molecular Glue Drug Discovery

September 9, 2025

Molecular glues show great potential for treating diseases such as cancer and neurodegeneration. This expert-led presentation will introduce WuXi Biology’s end-to-end molecular glue discovery platform....

Sign Up Now

Propelling Boundaries: Innovative Technologies in Early Drug Discovery

September 17, 2025

Join us for an exclusive webinar where experts from WuXi Biology will unveil the latest innovative technologies and products in small molecule and new molecule...

Sign Up Now